drugset
drugset / Trial / NCT00147511

Time To Efficacy and Onset Of Action Of Linezolid

NCT00147511 ↗

Phase 4 Completed 118 enrolled Pfizer
RandomizedParallel-groupOpen-labelTreatment

Summary

To assess the onset of action of linezolid

Timeline

Start
2003-06
Primary completion
—
Completion
2005-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Linezolid Other / unclassified — —

Indications

connective tissue disorder gram-positive bacterial infections